Question to the Department for International Trade:

To ask the Secretary of State for International Trade, what assessment she had made of the potential merits of including (a) covid-19 treatments, and (b) diagnostics in the Trade-Related Aspects of Intellectual Property Rights waiver negotiation.

The UK is engaging in the ongoing discussions taking place in the World Trade Organization, as Members consider extending the TRIPS Decision to COVID-19 therapeutics and diagnostics.

The UK approach will be evidence based.